Atropine 0.01% Eye Drops Did Not Slow Myopia Progression ...

Low-dose atropine eyedrops no better than placebo for slowing ...

Much stronger concentrations of atropine eyedrops (0.5-1.0%) have long been used by pediatric eye doctors to slow myopia progression. While ...

Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

Finding In this randomized clinical trial including 187 children, atropine, 0.01%, eye drops did not slow myopia progression or axial elongation ...

Atropine 0.01% Eye Drops Did Not Slow Myopia Progression ...

Some concentrations of low-dose atropine have been shown to modestly decrease myopia progression with children with low or moderate myopia, ...

Nearsighted progression in children is not slowed by very low dose ...

Stronger concentrations of atropine drops have been used by eye doctors for years to slow myopia progression, and while these higher doses have ...

Study: 0.01% atropine drops slow myopia progression, do ... - Healio

Atropine eye drops showed efficacy in slowing myopia progression. · The use of atropine did not aggravate intermittent exotropia.

Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control

Importance: Controlling myopia progression is of interest worldwide. Low-dose atropine eye drops have slowed progression in children in East ...

Low-dose atropine drops, 0.01%, ineffective in stopping myopia ...

The use of low-dose atropine 0.01% to slow the progression of myopia in children is not supported by a recent randomized clinical trial ...

0.01% Atropine Eye Drops in Children With Myopia and Intermittent ...

The 0.01% atropine group did not appear to have aggravated exotropia conditions, in terms of magnitude of exodeviation and exotropia control.

Proof not positive yet on low-dose atropine for myopia in children

The eye drops did not slow myopia progression or axial elongation, write that study's authors. The trial's children were from diverse races/ ...

Atropine drops fail to slow myopia in US children, study says - Healio

Two years of nightly atropine eye drops did not slow myopia progression or axial elongation in a cohort of U.S. children compared with ...

Atropine eye drops for myopia control in children | My Kids Vision

Atropine eye drops can be used to test and treat various eye conditions, and in low concentrations can slow myopia progression in children from age 4.

'Mixed results' of low-dose atropine for myopia - EyeWorld

The authors reported that the atropine treatment did not slow myopia progression or axial elongation. “These results do not support use of ...

Low-Concentration Atropine Eye Drops for Myopia Progression

However, its use was limited by the side effects of blurred near vision and photophobia. ATOM 2 study evaluated 0.5%, 0.1%, and 0.01% atropine on 400 myopic ...

US trial finds 0.01% atropine does not slow myopia progression

New research published in JAMA Ophthalmology has found 0.01% atropine eye drops did not slow myopia progression in a group of 187 US children.

Five-Year Clinical Trial on Atropine for the Treatment of Myopia 2

Over 5 years, atropine 0.01% eyedrops were more effective in slowing myopia progression with less visual side effects compared with higher doses of atropine.

To evaluate the age-related efficacy and safety of atropine 0.01% eye drops over 2 years for myopia control in a multicentric pediatric ...

Atropine eye drops for myopia control in teenagers | My Kids Vision

Atropine eye drops can be used to test and treat various eye conditions, and can slow myopia progression in teenagers with evidence up to age 16.

Five-Year Results of Atropine 0.01% Efficacy in Myopia Control in a ...

Topical low-dose atropine has become a popular myopia control treatment, and its ability to slow myopic progression has been widely studied.

In Clinical Trial, Atropine, 0.01% Eye Drops Did Not Slow Myopia ...

Recent studies have looked to low-dose atropine eye drops as an option to slow the progression of myopia in children, with positive results found in patients ...

The Lowdown on Low-dose Atropine - Review of Optometry

The researchers concluded that, over five years, the 0.01% atropine was effective in slowing myopia progression with limited side effects and rebound.